A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Clinical trial NCT03953079 · COMPLETED

Trial details

NCT number: NCT03953079
Sponsor: Graybug Vision
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration

Start date: 2019-09-26
Primary completion: 2020-12-15
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.